Copyright
©The Author(s) 2023.
World J Orthop. Jan 18, 2023; 14(1): 23-41
Published online Jan 18, 2023. doi: 10.5312/wjo.v14.i1.23
Published online Jan 18, 2023. doi: 10.5312/wjo.v14.i1.23
Table 1 Characteristics of included studies
Sl. No | Ref. | Country | Nature of study | Kellgren Lawrence Grade | Sample size | Treatment/ | Mean age (SD) | Male/female | MSC type | MSC source | Follow-up (mo) | ||
Treatment group | Control group | Treatment group | Control group | ||||||||||
1 | Vega et al[23], 2015 | Spain | RCT | II, III, IV | 30 | 15/15 | 56.6 ± 9.24 | 57.3 ± 9.09 | 06/09 | 05/10 | BM | Allo | 12 |
2 | Vangsness et al[24], 2014 | United States | RCT | NR | 55 | 36/19 | 44.6 ± 9.82 | 47.8 ± 8 | 25/11 | 13/06 | BM | Allo | 24 |
3 | Garay-Mendoza et al[25], 2018 | Mexico | RCT | NR | 61 | 30/31 | 55.57 ± 12.02 | 59.32 ± 10.85 | 07/23 | 09/22 | BM | Auto | 6 |
4 | Kuah et al[26], 2018 | Australia | RCT | I, II, III | 20 | 16/4 | 50.8 ± 7.29 | 55.0 ± 10.42 | 11/05 | 01/03 | AD | Allo | 12 |
5 | Estrada et al[22], 2020 | Argentina | RCT | I, II, III | 89 | 60/29 | 61 ± 12 | 61 ± 12 | NR | NR | BM / AD | Auto | 12 |
6 | Freitag et al[27], 2019 | Australia | RCT | II, III | 30 | 20/10 | 54.6 ± 6.3 | 51.5 ± 6.1 | 11/09 | 01/09 | AD | Auto | 12 |
7 | Ruane et al[41], 2021 | United States | RCT | I, II, III | 32 | 17/15 | 58.06 ± 9.14 | 58.6 ± 8.05 | 09/08 | 10/05 | BM | Auto | 12 |
8 | Lamo-Espinosa et al[28], 2016 | Spain | RCT | II, III, IV | 30 | 20/10 | 65.9 | 60.3 | 12/08 | 07/03 | BM | Auto | 12 |
9 | Garza et al[29], 2020 | United States | RCT | II, III | 39 | 26/13 | 60.5 ± 7.9 | 57.1 ± 9.1 | 15/11 | 7/6 | AD | Auto | 12 |
10 | Wong et al[30], 2013 | Singapore | RCT | NR | 56 | 28/28 | 53 | 49 | 15/13 | 14/14 | BM | Auto | 24 |
11 | Lu et al[31], 2019 | China | RCT | I, II, III | 53 | 27/26 | 55.03 ± 9.19 | 59.64 ± 5.97 | 03/24 | 03/23 | AD | Auto | 12 |
12 | Lv et al[42], 2015 | Huang | RCT | I, II | 80 | 40/40 | 55.9 ± 8.1 | 55.1 ± 6.8 | 14/26 | 13/27 | BM | Auto | 12 |
13 | Emadedin et al[32], 2018 | Iran | RCT | II, III, IV | 43 | 19/24 | 51.7 ± 9.2 | 54.7 ± 5.3 | 12/07 | 15/09 | BM | Auto | 6 |
14 | Gupta et al[33], 2016 | India | RCT | II, III | 60 | 40/20 | 58.10 ± 8.23 | 54.90 ± 8.27 | 12/28 | 4/16 | BM | Allo | 12 |
15 | Bastos et al[34], 2020 | Brazil | RCT | I, II, III, IV | 47 | 30/17 | 55.7 ± 7.8 | 55.9 ± 13.4 | 15/15 | 09/08 | BM | Auto | 12 |
16 | Wakitani et al[35], 2002 | Japan | I, II | 24 | 12/12 | NR | NR | NR | NR | BM | Auto | 16 | |
17 | Tran et al[36], 2019 | Taiwan | RCT | II, III | 33 | 15/18 | 58.2 ± 5.70 | 59.0 ± 6.04 | 03/12 | 05/13 | AD | Auto | 24 |
18 | Lee et al[37], 2019 | South Korea | RCT | II, III, IV | 24 | 12/12 | 62.2 ± 6.5 | 63.2 ± 4.2 | 03/09 | 03/09 | AD | Auto | 6 |
19 | Koh et al[38], 2012 | South Korea | RCT | IV | 50 | 25/25 | 54.2 ± 9.3 | 54.4 ± 11.3 | 08/17 | 08/17 | AD | Auto | 16 |
20 | Koh et al[39], 2014 | South Korea | RCT | I, II, III | 44 | 23/21 | 52.3 ± 4.9 | 54.2 ± 2.9 | 06/17 | 05/16 | AD | Auto | 24 |
21 | Hong et al[40], 2019 | China | RCT | II, III | 32 | 16/16 | 51 ± 5.95 | 53 ± 10.97 | 03/13 | 03/13 | AD | Auto | 12 |
- Citation: Muthu S, Patil SC, Jeyaraman N, Jeyaraman M, Gangadaran P, Rajendran RL, Oh EJ, Khanna M, Chung HY, Ahn BC. Comparative effectiveness of adipose-derived mesenchymal stromal cells in the management of knee osteoarthritis: A meta-analysis. World J Orthop 2023; 14(1): 23-41
- URL: https://www.wjgnet.com/2218-5836/full/v14/i1/23.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i1.23